Navigation Links
FDA approves drug tested by Scottsdale Healthcare and TGen
Date:9/6/2013

SCOTTSDALE, Ariz., Sept. 6, 2013 /PRNewswire-USNewswire/ -- The U.S. Food and Drug Administration today approved Abraxane for patients with advanced pancreatic cancer, following 7 years of rigorous clinical trials overseen by Scottsdale Healthcare and the Translational Genomics Research Institute (TGen).

(Logo: http://photos.prnewswire.com/prnh/20120201/DC45876)

Abraxane, the brand name for nab-paclitaxel, was approved for use in combination with gemcitabine, the previous standard drug therapy, following a large scale international clinical trial headed by Dr. Daniel D. Von Hoff, TGen Physician-in-Chief and Chief Scientific Officer at Scottsdale Healthcare's Virginia G. Piper Cancer Center Clinical Trials, a partnership of Scottsdale Healthcare and TGen.

"This is a new standard for treatment of metastatic pancreatic cancer that could become the backbone for other new treatment regimens," said Dr. Von Hoff, echoing the analysis he presented earlier this year at the annual meeting of the American Society of Clinical Oncology (ASCO). "The fact that Abraxane plus gemcitabine demonstrated an overall survival benefit is a significant step forward in offering new hope for our patients."

Dr. Von Hoff was the Principal Investigator of MPACT (Metastatic Pancreatic Adenocarcinoma Clinical Trial), the Phase III clinical study of 861 cancer patients at 121 sites in North America, Europe and Australia.

The study found that the combination of Abraxane and gemcitabine extended median overall survival by nearly 2 months, compared to gemcitabine alone — extending median survival to 8.5 months, from 6.7 months. The one-year median survival of patients increased to 35 percent, from 22 p
'/>"/>

SOURCE Scottsdale Healthcare
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Novogen Board Approves US$4 Million Investment In Marshall Edwards Rights Offering
2. FDA Approves NDA Supported By MedAvante Central Ratings
3. Cardinal Health Board Of Directors Approves Cash Dividend; Authorizes New $750 Million Share Repurchase Program
4. FDA Approves Neuralstem To Treat Final Cohort In NSI-189 Phase Ib Trial In Major Depressive Disorder
5. Specialty Pharmacy Certification Board (SPCB) Approves Content for Certified Specialty Pharmacist (CSP) Certification Exam
6. FDA APPROVES APTIMA HPV ASSAY FOR USE ON HOLOGICS PANTHER SYSTEM
7. FDA Approves Epaned, a Liquid Form of Enalapril for Children and Adults
8. Baby Boomers Should Get Tested for Hepatitis C
9. Health Diagnostic Laboratory, Inc. Provides Grant to Support National Lipid Association, Sponsors 2012 Annual Scientific Sessions in Scottsdale, Arizona
10. Scottsdale Healthcare, TGen study shows Abraxane/gemcitabine combination extends survival of pancreatic cancer patients
11. Clinical Trial at Evergreen Healthcare Shows Intestinal Gel Reduces Symptoms of Advanced Parkinsons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)... , May 27, 2015  Frisbie Memorial ... Accreditation renewal in CT scanning for adult and ... have been granted ACR Accreditation: CT, Ultrasound, MRI, ... seal of accreditation represents the highest level of ... medical physicists who are experts in the field ...
(Date:5/27/2015)... 2015  Sequenom, Inc. (NASDAQ: SQNM ), a ... the development of innovative products and services, today announced ... its laboratory operations in Grand Rapids, Michigan ... Durham , North Carolina.  Sequenom Laboratories, cystic fibrosis ... North Carolina laboratory location.  ...
(Date:5/27/2015)... , May 27, 2015 PharmaPoint: Systemic Lupus ... Market Analysis to 2022 - Event-Driven Update ... generics and GlaxoSmithKline,s Benlysta is the only drug that ... 50 years. Following Benlysta,s launch, patients, uptake has remained ... has managed to grow the lupus market in terms ...
Breaking Medicine Technology:Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 2Sequenom Laboratories To Consolidate Michigan And North Carolina Facilities 3PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 2PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2022 - Event-Driven Update 3
... , , SCOTTSDALE, Ariz., July 15 ... for many who fear Alzheimer,s disease . Now a ... New England Journal of Medicine suggests that the carriers of a common ... their mid-50s, far earlier than previously thought. , , ...
... , , , NEW YORK, ... today announced approximately $2.1 million in total funding to 10 research ... , Target validation is an essential ... to determine whether a molecule or mechanism of interest is a ...
Cached Medicine Technology:Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 2Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 3Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 4Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 5Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 6Mayo Clinic Study Finds Earliest Evidence of Memory Decline in Middle-Aged People at Genetic Risk for Alzheimer's Disease 7Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets 2Michael J. Fox Foundation Awards Over $2 Million for Validation of 10 Parkinson's Therapeutic Targets 3
(Date:5/28/2015)... Atlanta-based Thrive Senior Living has announced ... summer on an innovative new Assisted Living community in ... connectivity in a unique, resort-like environment, Thrive at Jones ... southern hospitality to create a distinctive experience for a ... will feature luxuriously appointed resident apartments, a spa, beauty ...
(Date:5/28/2015)... 28, 2015 The second episode of ... people who share a need to transform their lives. Josh ... Omaha, NE, struggling to deal with the death of his ... player from Kansas City, MO, who went into depression after ... amazing transformations will be featured in one episode of “Extreme ...
(Date:5/27/2015)... Cincinnati, Ohio (PRWEB) May 28, 2015 ... to an informational Open House May 30 from noon-2p.m. ... to learn about how caregivers can offer full-time assistance ... are approved through a comprehensive survey process conducted by ... a personal residence as a medical foster home, the ...
(Date:5/27/2015)... San Diego, CA (PRWEB) May 27, 2015 ... sharing and teleradiology services, is pleased to introduce Mr. ... Mr. Hafey has a proven track record of ... the healthcare information technology domain. He most recently served ... and previously held the role of Chief Architect for ...
(Date:5/27/2015)... Cleveland, OH (PRWEB) May 27, 2015 Ticket Down ... tickets . The Cavs have been super hot during the ... the Hawks by 30 points with a final score of 118-88. ... to the NBA Finals since 2006-2007 when they lost to ... this past summer, the chances of the Cavaliers making it to ...
Breaking Medicine News(10 mins):Health News:Thrive Announces Innovative New Senior Living Community in Huntsville, AL 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 2Health News:“Extreme Weight Loss”: Josh and Kelli’s Journeys Begin at the University of Colorado Anschutz Health and Wellness Center 3Health News:StatRad Introduces Mr. Chris E. Hafey as Chief Technology Officer, and the Release of its Advanced Pure HTML5 DICOM Image Uploader 2Health News:Cavs NBA Finals Tickets: Ticket Down Slashes Ticket Prices on Cleveland Cavaliers 2015 NBA Finals Tickets at Quicken Loans Arena and Offers Valuable Promo Code 2
... ventilators, dialysis machines, agency says safety an issue, , ... ages and medical technology improves, more people are using ... at home, adding to the need for better-educated patients. ... and Drug Administration announced Tuesday that it has started ...
... D.C. Levels of epidermal growth factor receptor (EGFR) may ... prior to their breast cancer diagnosis, according to findings presented ... 2010, held here April 17-21. The goal of the ... of the Epidemiology Program at the Fred Hutchinson Cancer Research ...
... MA and Hyde Park, NY -- Responding to the health ... department of nutrition at Harvard School of Public Health (HSPH) ... sodium reduction strategies that are strong and effectiveand that maximize ... now overwhelming evidence that we must treat sodium reduction as ...
... who metabolize nicotine slowly may need to wear nicotine patch ... New research suggests that a set length of time for ... trying to kick the habit. , Researchers at the University ... people -- about three-quarters of smokers -- break down ...
... Deepak Srivastava, MD, director of the Gladstone Institute of ... UCSF, has been elected to the American Academy of ... W. Mahley as a member of the Academy. Established ... fathers, the Academy is one of the nation,s oldest ...
... ... Incentives Are Still Available , ... (Vocus) April 20, 2010 -- Toll Brothers, the nation,s leading builder of luxury homes, ... until May 2. With the slight rise in interest rates recently, and conventional wisdom pointing ...
Cached Medicine News:Health News:FDA Tightens Oversight of Home Medical Devices 2Health News:FDA Tightens Oversight of Home Medical Devices 3Health News:Increased EGFR levels may be an early marker of breast cancer 2Health News:Experts call for accelerated national sodium reduction initiatives 2Health News:Experts call for accelerated national sodium reduction initiatives 3Health News:Experts call for accelerated national sodium reduction initiatives 4Health News:Tailored Therapy May Help More Stop Smoking 2Health News:Gladstone's Deepak Srivastava elected to the American Academy of Arts and Sciences 2Health News:Spring Into A New Toll Brothers Dream Home During the National Spring Sales Event April 24 - May 2 2Health News:Spring Into A New Toll Brothers Dream Home During the National Spring Sales Event April 24 - May 2 3Health News:Spring Into A New Toll Brothers Dream Home During the National Spring Sales Event April 24 - May 2 4
... the surgical table to a new level ... perfect table complement for any fracture procedure. ... in the surgical process, the PROfx table ... surgeon to minimize the invasiveness of procedures ...
... Growth Stimulators are portable, battery-powered medical devices ... of an established nonunion fracture acquired secondary ... bones. , ,Clinical studies ... of 60.7% in patients with nonunions that ...
... Linvatec cannulated interference screws have ... limit screw divergence. Screws are ... five lengths. Screws are supplied ... 8mm, and 9mm dia. (screws ...
Cannulated Interference Screws...
Medicine Products: